Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsCopenhagen, Denmark, September 12, ...
Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2...
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsCopenhagen, Denmark, August 22, 202...
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European ...
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") (CVR-no. 20045078) a biotechnology company focused on the discovery and d...
Company announcement – No. 43 / 2022 Zealand Pharma announces directed issue and private placement of approximately 4.5m new s...
Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1) ...
Press release – No. 6 / 2022 Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeti...
